MiR-486-3p targeting ECM1 represses cell proliferation and metastasis in cervical cancer

Granados López, 2014, Multistep model of cervical cancer: participation of miRNAs and coding genes, Int. J. Mol. Sci., 15, 15700, 10.3390/ijms150915700 Banno, 2014, MicroRNA in cervical cancer: oncomiRs and tumor suppressor miRs in diagnosis and treatment, Sci. World J., 2014, 178075, 10.1155/2014/178075 Banno, 2014, Application of microRNA in diagnosis and treatment of ovarian cancer, Biomed. Res. Int., 2014, 10.1155/2014/232817 Kuhlmann, 2012, microRNA and the pathogenesis of ovarian cancer?a new horizon for molecular diagnostics and treatment?, Clin. Chem. Lab. Med., 50, 601 Maldonado, 2010, Epigenomics and ovarian carcinoma, Biomark. Med., 4, 543, 10.2217/bmm.10.72 Asadollahi, 2010, Epigenetics of ovarian cancer: from the lab to the clinic, Gynecol. Oncol., 118, 81, 10.1016/j.ygyno.2010.03.015 Guo, 2015, MiR-346 up-regulates argonaute 2 (AGO2) protein expression to augment the activity of other MiRNAs and contributes to cervical cancer cell malignancy, J. Biol. Chem. Song, 2015, miR-346 and miR-138 competitively regulate hTERT in GRSF1- and AGO2-dependent manners, respectively, Sci. Rep., 5, 15793, 10.1038/srep15793 Li, 2015, CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells, Oncotarget, 6, 34924, 10.18632/oncotarget.5318 Safari, 2015, Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer, Tumour Biol. Mao, 2015, Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer, Am. J. Cancer Res., 5, 1939 Zhao, 2014, Circulating MicroRNAs in gynecological malignancies: from detection to prediction, Exp. Hematol. Oncol., 3, 14, 10.1186/2162-3619-3-14 Banno, 2014, MicroRNA in cervical cancer: oncomiRs and tumor suppressor miRs in diagnosis and treatment, Sci. World J., 2014, 178075, 10.1155/2014/178075 Venkatesan, 2015, Computational and in vitro investigation of miRNA-Gene regulations in retinoblastoma pathogenesis: miRNA mimics strategy, Bioinform. Biol. Insights, 9, 89, 10.4137/BBI.S21742 Hummel, 2011, Hussey DJ.Chemotherapy-induced modification of microRNA expression in esophageal cancer, Oncol. Rep., 26, 1011 Swierniak, 2013, In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma, J. Clin. Endocrinol. Metab., 98, E1401, 10.1210/jc.2013-1214 Lee, 2015, ECM1 regulates tumor metastasis and CSC-like property through stabilization of β-catenin, Oncogene Lee, 2015, ECM1 promotes the Warburg effect through EGF-mediated activation of PKM2, Cell. Signal., 27, 228, 10.1016/j.cellsig.2014.11.004 Paroly, 2013, Stromal protein Ecm1 regulates ureteric bud patterning and branching, PLoS One, 8, e84155, 10.1371/journal.pone.0084155 Lee, 2014, Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling, Breast Cancer Res., 16, 479, 10.1186/s13058-014-0479-6 Wu, 2014, Extracellular matrix protein 1 is correlated to carcinogenesis and lymphatic metastasis of human gastric cancer, World J. Surg. Oncol., 12, 132, 10.1186/1477-7819-12-132 Gu, 2013, Correlation of ECM1 expression level with the pathogenesis and metastasis of laryngeal carcinoma, Int. J. Clin. Exp. Pathol., 6, 1132 Lal, 2013, Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C, PLoS One, 8, e73953, 10.1371/journal.pone.0073953 Triulzi, 2013, Balsari A,Ménard S, Orlandi R, Tagliabue E: Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress, PLoS One, 8, e56761, 10.1371/journal.pone.0056761